lost weight on semaglutide but not tirzepatide Woman shares journey of loss and gain after using Semaglutide & Tirzepatide Weight Loss

Mitochondrial dysfunction is a central feature of PD pathogenesis, especially through interference with Complex I and Complex II of the electron transport chain (ETC)

Saving the setup in PepSync helps avoid re-entering the same details each week

Clinical trials demonstrate that tirzepatide alone produces substantial weight loss when: Doses are appropriately titrated (starting at 2.5 mg weekly, increasing by 2.5 mg every 4 weeks as tolerated up to 15 mg) Treatment is combined with comprehensive lifestyle modification Patients receive ongoing dietary counselling and behavioural support Adequate time is allowed (typically 612 months) to assess full therapeutic effect Many patients who feel treatment is insufficient may benefit from dose optimisation or addressing adherence barriers rather than adding another medication

Changes in blood sugar regulation, altered eating patterns, and the general metabolic shift that accompanies significant weight loss may all contribute

Our clinicians at Klinic will evaluate your situation thoroughly to determine the suitability of tirzepatide treatment

The tradeoff is lower bioavailability compared to injectable semaglutide